Funder: National Institutes of Health (NIH)
Due Dates: February 24, 2025 | February 23, 2026 | September 4, 2026
Funding Amounts: Up to $350,000/year (Phase I, 1 year) | Up to $2.15M/year (Phase II, 2 years)
Summary: Supports U.S. small businesses to develop and commercialize automated, miniaturized tissue chip platforms for biomedical research and drug development.
Key Information: Only U.S. small businesses are eligible; non-domestic entities/components not allowed.